baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Bonus Zert AMD 31.12.2024/ DE000VM96E26 /

13/05/2024 08:39:58	Chg.-0.81	Bid22:00:06	Ask22:00:06	Underlying	Strike price	Expiration date	Option type
142.23EUR	-0.57%	- Bid Size: -	- Ask Size: -	Advanced Micro Devic...	- USD	31/12/2024	Call

GlobeNewswire 13/05 Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...

GlobeNewswire 13/05 Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

GlobeNewswire 13/05 AMD Remains the Partner of Choice for World’s Fastest and Most Efficient High Performance Computing ...

GlobeNewswire 09/05 Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 09/05 Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlight...

GlobeNewswire 09/05 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire 08/05 Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progress...

GlobeNewswire 08/05 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...

GlobeNewswire 08/05 AMD Receives IEEE 2024 Corporate Innovation Award for Leadership in Chiplet Design for High-Performa...

GlobeNewswire 08/05 Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

GlobeNewswire 08/05 EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporat...

GlobeNewswire 07/05 Ocular Therapeutix™ Reports First Quarter 2024 Results

GlobeNewswire 07/05 Optiver Chooses AMD Enterprise Portfolio to Power its Data Center Modernization, Enabling New Era of...

GlobeNewswire 07/05 Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results

GlobeNewswire 07/05 Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 06/05 Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD

GlobeNewswire 06/05 Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease ...

GlobeNewswire 06/05 Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...

GlobeNewswire 06/05 Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences

GlobeNewswire 06/05 EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Prol...

GlobeNewswire 03/05 Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024

GlobeNewswire 03/05 YieldMax™ ETFs Announces Monthly Distributions on CONY (109.51%), MSTY (103.22%), NFLY (67.74%), SQY...

GlobeNewswire 02/05 Outlook Therapeutics® to Present at the Retina World Congress 2024

GlobeNewswire 02/05 Kriya Announces Three Presentations at the 2024 Association for Research in Vision and Ophthalmology...

GlobeNewswire 02/05 YieldMax™ Launches Short TSLA Option Income Strategy ETF CRSH

BVT Bonus Zert AMD 31.12.2024/ DE000VM96E26 /

If you wish to receive reply to your feedback, please provide your email address.